Carregant...
Efficacy of Brinzolamide Ophthalmic Suspension 1% for Treatment of a Vitelliform Macular Lesion in a Patient with Desferrioxamine Retinopathy
A 46-year-old Caucasian woman with a vitelliform macular lesion secondary to desferrioxamine (DFO) retinal toxicity in the right eye was treated with brinzolamide 1% ophthalmic drops three times a day. A spectral-domain OCT (SD-OCT) unit was used to monitor any changes in the macular lesion. After 2...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2011
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3733098/ https://ncbi.nlm.nih.gov/pubmed/22150599 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3928/15428877-20111201-03 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|